Paige AI
First FDA-authorized AI for prostate cancer detection with 70% higher sensitivity than unaided pathologists.
Why choose Paige AI
Paige AI is a clinical-grade AI platform for computational pathology. Paige Prostate, its flagship product, is the first FDA-authorized AI to assist pathologists in prostate cancer detection, identifying cancerous tissue with 70% higher sensitivity than unaided pathologists. Paige serves pharmaceutical companies and reference laboratories for oncology biomarker analysis.
- Only FDA-authorized prostate cancer AI
- Proven 70% sensitivity improvement
- Trusted by pharmaceutical companies
- Strong clinical evidence
Where it falls short
- Narrow initial indication scope
- Enterprise pricing
- Requires digital pathology infrastructure
Best for these users
Pricing overview
Key features
Alternatives to Paige AI
DeepMind's AI that predicts protein structures with atomic accuracy, transforming drug discovery.
Microsoft's ambient clinical AI that auto-generates structured notes from patient conversations.
AI voice assistant that automates clinical documentation for healthcare professionals.
Related comparisons
The verdict
Paige AI is a solid choice for business teams who need only fda-authorized prostate cancer ai. At paid, it delivers good value. Main caveat: narrow initial indication scope. Compare with alternatives before committing.